Bg pattern

MEMANTINE MYLAN 20 mg FILM-COATED TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use MEMANTINE MYLAN 20 mg FILM-COATED TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the Patient

Memantina Mylan 20 mg Film-Coated Tablets EFG

Memantine Hydrochloride

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the Package Leaflet

  1. What is Memantina Mylan and what is it used for
  2. What you need to know before you take Memantina Mylan
  3. How to take Memantina Mylan
  4. Possible side effects
  5. Storage of Memantina Mylan
  6. Contents of the pack and other information

1. What is Memantina Mylan and what is it used for

Memantina Mylan contains the active substance memantine. It belongs to a group of medicines called anti-dementia medicines. Memory loss in Alzheimer's disease is due to a disturbance of message signals in the brain. The brain contains so-called N-methyl-D-aspartate (NMDA) receptors that are involved in the transmission of nerve signals important for learning and memory. Memantina Mylan belongs to a group of medicines called NMDA receptor antagonists. Memantina Mylan acts on these receptors improving the transmission of nerve signals and memory.

Memantina Mylan is used for the treatment of patients with moderate to severe Alzheimer's disease.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you take Memantina Mylan

Do not take Memantina Mylan:

  • if you are allergic to memantine or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Consult your doctor or pharmacist before taking Memantina Mylan.

  • if you have a history of epileptic seizures
  • if you have recently suffered from myocardial infarction (heart attack), if you suffer from congestive heart failure or if you have uncontrolled hypertension (high blood pressure).

In these situations, treatment must be carefully supervised and your doctor must regularly re-evaluate the clinical benefit of Memantina Mylan.

If you have kidney problems, your doctor should closely monitor your kidney function and if necessary, adjust the dose of memantine.

The use of memantine should be avoided in combination with other medicines such as amantadine (for the treatment of Parkinson's disease), ketamine (a medicine generally used to produce anesthesia), dextromethorphan (a medicine for the treatment of cough) and other NMDA antagonists.

Children and adolescents:

Memantina Mylan is not recommended for use in children below 18 years of age.

Use of Memantina Mylan with other medicines

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

In particular, the administration of Memantina Mylan may cause changes in the effects of the following medicines, so your doctor may need to adjust the dose:

  • amantadine, ketamine, dextromethorphan
  • dantrolene, baclofen
  • cimetidine, ranitidine, procainamide, quinidine, quinine, nicotine
  • hydrochlorothiazide (or any combination with hydrochlorothiazide)
  • anticholinergics (substances generally used to treat movement disorders or intestinal spasms)
  • anticonvulsants (substances used to prevent and eliminate convulsions)
  • barbiturates (substances generally used to induce sleep)
  • dopaminergic agonists (substances such as L-dopa, bromocriptine)
  • neuroleptics (substances used in the treatment of mental illnesses)
  • oral anticoagulants

If you are admitted to hospital, inform your doctor that you are taking Memantina Mylan.

Taking Memantina Mylan with food and drinks

You should inform your doctor if you have recently changed or intend to change your diet considerably (e.g. from normal to strict vegetarian) or if you suffer from renal tubular acidosis (RTA, excess of acid-producing substances in the blood due to kidney dysfunction) or severe urinary tract infections, as your doctor may need to adjust the dose of the medicine.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Pregnancy

Memantine is not recommended for use in pregnant women.

Breast-feeding

Memantina Mylan is contraindicated during breast-feeding.

Driving and using machines

Your illness may affect your ability to drive or use machines and you should not carry out these activities unless your doctor tells you it is safe to do so. Memantina Mylan may cause dizziness and somnolence, mainly at the start of treatment or when increasing the dose. If you experience these effects, you should not drive or use machines.

Memantina Mylan contains sodium

This medicine contains less than 23 mg of sodium (1 mmol) per tablet; this is essentially “sodium-free”.

3. How to take Memantina Mylan

Follow exactly the administration instructions given by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.

Posology

The recommended dose of Memantina Mylan for adults and elderly patients is 20 mg once a day.

To reduce the risk of side effects, this dose is achieved gradually by following the following daily therapeutic scheme. Other concentrations of the tablet are available for dose escalation.

Week 1

half a 10 mg tablet

Week 2

one 10 mg tablet

Week 3

one and a half 10 mg tablets

From week 4 onwards

one 20 mg tablet once a day

The normal starting dose is half a 10 mg tablet once a day (5 mg) for the first week. It is increased to one 10 mg tablet once a day (10 mg) for the second week and to one and a half 10 mg tablets once a day for the third week. From the fourth week onwards, the normal dose is one 20 mg tablet administered once a day (20 mg).

Posology for patients with renal impairment

If you have kidney problems, your doctor will decide on the appropriate dose for your condition. In this case, your doctor should regularly monitor your kidney function.

Administration

Memantina Mylan should be administered orally once a day. To get the most out of your medication, you should take it every day and at the same time. The tablets should be swallowed with a little water. The tablets can be taken with or without food.

Duration of treatment

Continue taking Memantina Mylan as long as it is beneficial for you. Your doctor should evaluate the effects of your treatment periodically.

If you take more Memantina Mylan than you should

  • Generally, taking too much Memantina Mylan should not harm you. You may experience an increase in the symptoms described in section 4 “Possible side effects”.
  • If you take an overdose of Memantina Mylan, contact your doctor or seek medical advice, as you may need medical attention.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, telephone: 91 562 04 20, indicating the medicine and the amount ingested.

If you forget to take Memantina Mylan

  • If you realize that you have forgotten to take your dose of Memantina Mylan, wait and take the next dose at the usual time.
  • Do not take a double dose to make up for the forgotten dose.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Generally, side effects are mild to moderate.

Common (may affect up to 1 in 10 people):

  • Headache, somnolence, constipation, elevated liver function tests, dizziness, balance disorder, shortness of breath, high blood pressure and hypersensitivity to the medicine.

Uncommon (may affect up to 1 in 100 people):

  • Fatigue, fungal infections, confusion, hallucinations, vomiting, gait disturbance, heart failure and formation of blood clots in the venous system (thrombosis/thromboembolism).

Rare (may affect up to 1 in 10,000 people):

  • Seizures

Frequency not known (cannot be estimated from the available data):

  • Pancreatitis, hepatitis (inflammation of the liver) and psychotic reactions.

Alzheimer's disease has been associated with depression, suicidal ideation and suicide. These events have been reported in patients treated with memantine hydrochloride.

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V*. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Memantina Mylan

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton, after EXP. The expiry date refers to the last day of the month shown.

No special storage conditions are required.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Contents of the pack and other information

Composition of Memantina Mylan

  • The active substance is memantine. Each film-coated tablet contains 20 mg of memantine hydrochloride, equivalent to 16.62 mg of memantine.
  • The other ingredients are microcrystalline cellulose, sodium croscarmellose (see section 2 “Memantina Mylan contains sodium”), magnesium stearate, talc and anhydrous colloidal silica, in the tablet core; polydextrose (E1200), hypromellose 3cP (E464), hypromellose 6cP (E464), hypromellose 50cP (E464), red iron oxide (E 172), macrogol 400 (E1521) and macrogol 8000, in the tablet coating.

Appearance of Memantina Mylan and contents of the pack

Memantina Mylan is presented in the form of film-coated tablets, red, oval, biconvex, with a bisected edge, engraved with “ME” on one face of the tablet and “20” on the other.

Memantina Mylan is presented in blister packs of 7, 10, 14, 28, 28 x 1, 30, 42, 50, 56, 56 x 1, 60, 70, 84, 98, 98 x 1, 100, 100 x 1 or 112 film-coated tablets.

Pack sizes of 28 x 1, 56 x 1, 98 x 1 and 100 x 1 film-coated tablets are presented in unit-dose blisters.

Not all pack sizes may be marketed.

Marketing authorisation holder

Mylan Pharmaceuticals Limited

Damastown Industrial Park,

Mulhuddart, Dublin 15,

DUBLIN

Ireland

Manufacturer

McDermott Laboratories Ltd. T/A Gerard Laboratories

Unit 35 Baldoyle Industrial Estate, Grange Road, Dublin 13, Ireland.

Mylan Hungary Kft.

H-2900 Komárom, Mylan utca. 1, Hungary.

You can request more information about this medicine from the local representative of the marketing authorisation holder:

België/Belgique/Belgien

Mylan bvba/sprl

Tél/Tel: + 32 (0)2 658 61 00

Lietuva

Mylan Healthcare UAB

Tel: +370 5 205 1288

Text in Bulgarian language including the name Майлан ЕООД and a phone number +359 2 44 55 400

Luxembourg/Luxemburg

Mylan bvba/sprl

Tél/Tel: + 32 (0)2 658 61 00

(Belgique/Belgien)

Ceská republika

Viatris CZ s.r.o.

Tel: +420 222 004 400

Magyarország

Mylan EPD Kft

Tel.: + 36 1 465 2100

Danmark

Viatris ApS

Tlf: +45 28 11 69 32

Malta

V.J. Salomone Pharma Ltd

Tel: + 356 21 22 01 74

Deutschland

Viatris Healthcare GmbH

Tel: +49 800 0700 800

Nederland

Mylan BV

Tel: +31 (0)20 426 3300

Eesti

BGP Products Switzerland GmbH Eesti

filiaal

Tel: +372 6363 052

Norge

Viatris AS

Tlf: +47 66 75 33 00

Ελλáδα

Generics Pharma Hellas ΕΠΕ

Τηλ: +30 210 993 6410

Österreich

Arcana Arzneimittel GmbH

Tel: +43 1 416 2418

España

Viatris Pharmaceuticals, S.L.U.

Tel: + 34 900 102 712

Polska

Mylan Healthcare Sp. z.o.o.

Tel: + 48 22 546 64 00

France

Viatris Santé

Tel: + 33 4 37 25 75 00

Portugal

Mylan, Lda.

Tel: + 351 214 127 200

Hrvatska

Mylan Hrvatska d.o.o.

Tel: +385 1 23 50 599

România

BGP Products SRL

Tel: +40 372 579 000

Ireland

Mylan Ireland Limited

Tel: +353 1 8711600

Slovenija

Viatris d.o.o.

Tel: + 386 1 23 63 180

Ísland

Icepharma hf.

Sími: +354 540 8000

Slovenská republika

Viatris Slovakia s.r.o.

Tel: +421 2 32 199 100

Italia

Mylan Italia S.r.l.

Tel: + 39 02 612 46921

Suomi/Finland

Viatris Oy

Puh/Tel: +358 20 720 9555

Κúπρος

Varnavas Hadjipanayis Ltd.

Τηλ: +357 2220 7700

Sverige

Viatris AB

Tel: +46 (0)8 630 19 00

Latvija

Mylan Healthcare SIA

Tel: +371 676 055 80

United Kingdom (Northern Ireland)

Mylan IRE Healthcare Limited

Tel: +353 18711600

Date of last revision of this leaflet: {MM/AAAA}.

Other sources of information

Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu.

Online doctors for MEMANTINE MYLAN 20 mg FILM-COATED TABLETS

Discuss questions about MEMANTINE MYLAN 20 mg FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (5)
Doctor

Anastasiia Hladkykh

Psychiatry 15 years exp.

Dr Anastasiia Hladkykh is a physician-psychotherapist and psychologist with over 14 years of experience working with individuals struggling with various types of addictions and their families. She provides online consultations for adults, combining medical knowledge with deep psychological support and practical tools.

Key areas of expertise:

  • Addiction treatment: alcohol and drug dependence, gambling addiction, compulsive behaviours, codependent relationships.
  • Support for families of addicted individuals, behavioural correction within the family system, guidance for maintaining remission.
  • Mental health: depression, bipolar disorder, obsessive-compulsive disorder (OCD), anxiety disorders, phobias, PTSD, generalised anxiety, emotional trauma, and the psychological impact of loss or emigration.
  • Psychoeducation: explaining complex mental health concepts in simple language, helping patients and their families understand diagnoses and treatment steps.
Therapeutic approach:
  • Client-centred, straightforward, and empathetic – focused on practical outcomes and emotional stabilisation.
  • Prescribes medications when needed, but always aims to minimise unnecessary pharmaceutical use.
  • Certified in multiple evidence-based methods: CBT, NLP (Master Practitioner), Ericksonian hypnosis, symbol drama, art therapy, and systemic therapy.
  • Each consultation results in a clear, structured plan – patients leave knowing exactly what to do next.
Experience and background:
  • Member of the German association Gesundheitpraktikerin and the NGO “Mit dem Sonne in jedem Herzen.”
  • More than 18 publications in international peer-reviewed journals, translated into several languages.
  • Volunteer work with Ukrainian refugees and military personnel at the University Clinic of Regensburg.
Camera Book a video appointment
€130
0.0 (1)
Doctor

Daria Portnova

Psychiatry 31 years exp.

Dr Daria Portnova is a psychiatrist and psychotherapist with over 30 years of clinical experience. She works with adults and adolescents aged 14 and over, providing online psychiatric and psychotherapeutic consultations.

In her practice, Dr Portnova supports patients facing the onset of mental health conditions, chronic psychiatric disorders, psychotic symptoms, trauma-related states, and complex emotional crises. Her work is structured and safety-focused, with an emphasis on stabilisation, accurate diagnosis, and long-term improvement in quality of life.

Patients consult Dr Daria Portnova for the following concerns:

  • existential crises and complex life situations;
  • loss, grief, and emotional exhaustion;
  • relationship difficulties, separation, and divorce;
  • psychological and psychiatric trauma, including complex PTSD (cPTSD);
  • anxiety disorders: generalised anxiety disorder and panic disorder;
  • social anxiety and social phobia;
  • obsessive-compulsive disorder (OCD);
  • sleep disorders;
  • depressive disorders;
  • bipolar affective disorder;
  • schizoaffective disorder;
  • schizophrenia;
  • personality disorders.
Dr Portnova combines psychiatric assessment with a psychotherapeutic approach. She works with evidence-based methods, including cognitive behavioural therapy (CBT) and third-wave approaches such as ACT, FACT, and CFT. Consultations are focused on clear clinical understanding, practical recommendations, and ongoing support over time.
Camera Book a video appointment
€110
5.0 (77)
Doctor

Sergey Ilyasov

Psychiatry 7 years exp.

Dr Sergey Ilyasov is an experienced neurologist and qualified psychiatrist who provides online consultations for adults and adolescents. Combining deep neurological expertise with a modern psychiatric approach, he ensures comprehensive diagnostics and effective treatment for a wide range of conditions affecting both physical and mental health.

Dr. Ilyasov helps patients in the following cases:

  • Chronic headaches (migraine, tension-type headache), back pain, neuropathic pain, dizziness, numbness in limbs, coordination disorders.
  • Anxiety disorders (panic attacks, generalized anxiety disorder), depression (including atypical and treatment-resistant forms), sleep disturbances (insomnia, hypersomnia, nightmares), stress, burnout.
  • Chronic pain syndromes and psychosomatic symptoms (e.g., irritable bowel syndrome related to stress, vegetative-vascular dystonia).
  • Behavioral disorders and concentration difficulties in adolescents (including ADHD, autism spectrum disorders), nervous tics.
  • Memory impairments, phobias, obsessive-compulsive disorder (OCD), emotional swings, and support for post-traumatic stress disorder (PTSD).

Thanks to his dual specialization in neurology and psychiatry, Dr Sergey Ilyasov offers integrated and evidence-based care for complex conditions requiring a multidisciplinary approach. His consultations focus on accurate diagnosis, development of an individualized treatment plan (including pharmacotherapy and psychotherapeutic methods), and long-term support adapted to each patient's unique needs.

Book an online consultation with Dr. Sergey Ilyasov to receive qualified assistance and improve your well-being today.

Camera Book a video appointment
€89
5.0 (137)
Doctor

Taisiia Proida

Psychiatry 7 years exp.

Dr. Taisiia Proida is a psychiatrist and cognitive behavioural therapist (CBT), and a member of the European Psychiatric Association. She offers online consultations for adults aged 18 and over, combining evidence-based medicine with an individualised approach to mental health care.

She specialises in consultations and ongoing support for a wide range of mental health concerns, including:

  • Mood disorders: depression, bipolar disorder, postpartum depression.
  • Anxiety disorders: generalised anxiety, OCD, panic attacks, phobias.
  • Post-traumatic stress disorder (PTSD) and complex PTSD.
  • Attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Assessment is provided only after an initial psychiatric evaluation and during a follow-up appointment.
  • Personality disorders and emotional instability.
  • Cyclothymia and mood fluctuations.
  • Schizophrenia spectrum and related conditions.

Dr. Proida combines clinical expertise with an empathetic approach, offering structured support based on evidence-based practices. Her work integrates CBT techniques with medical management, with a focus on anxiety and depressive disorders.

She works with clients from different countries and cultural backgrounds, adapting her communication style and recommendations to individual needs. With experience in international clinical trials (Pfizer, Merck), she values clarity, trust, and collaborative partnership in patient care.

Camera Book a video appointment
€120

Frequently Asked Questions

Is a prescription required for MEMANTINE MYLAN 20 mg FILM-COATED TABLETS?
MEMANTINE MYLAN 20 mg FILM-COATED TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in MEMANTINE MYLAN 20 mg FILM-COATED TABLETS?
The active ingredient in MEMANTINE MYLAN 20 mg FILM-COATED TABLETS is memantine. This information helps identify medicines with the same composition but different brand names.
Who manufactures MEMANTINE MYLAN 20 mg FILM-COATED TABLETS?
MEMANTINE MYLAN 20 mg FILM-COATED TABLETS is manufactured by Mylan Pharmaceuticals Limited. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of MEMANTINE MYLAN 20 mg FILM-COATED TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether MEMANTINE MYLAN 20 mg FILM-COATED TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to MEMANTINE MYLAN 20 mg FILM-COATED TABLETS?
Other medicines with the same active substance (memantine) include AXURA 10 mg FILM-COATED TABLETS, AXURA 10 mg FILM-COATED TABLETS, AXURA 20 mg FILM-COATED TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media